Company intelligence / Profile preview

Everest Group

New York City, New York, United Stateseverestgrp.com ↗

Ownership: Public · EG
Development stage: Other

Overview

Everest Group is a leading global research and consulting firm that partners with organizations in the life sciences industry—including pharma and biotech companies—to provide strategic insights, market analysis, and operational guidance. It does not develop drugs or own clinical programs but supports healthcare clients through advisory services[1][3][5].

Industry: Consulting

Partnerships

Indegene (recognized as a front-runner in GenAI by Everest Group)

Financials

Market cap: $14.6B
Total revenue: $4B
Enterprise value: $14.6B

Beyond the preview

Go deeper on Everest Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Everest Group.

Explore the full profile